Tag Archives: tebipenem

Playing To Win: Scenario Planning For Binary Readouts In Biotech
October 8, 2020

By Ankit Mahadevia, CEO of Spero Therapeutics, as part of the From The Trenches feature of LifeSciVC Earlier this fall, we prepared to report Phase III data for tebipenem HBr, our oral medication that, if approved, could help 2.7M patients

Leave a comment